1. Home
  2. Live Updates
  3. Heron therapeutics inc

Heron Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heron therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heron Therapeutics Inc Today - Breaking & Trending Today

Connect Biopharma : INFORMATION CONTAINED IN THIS REPORT ON FORM 6 K Form 6 K

Document



















UNITED STATES


SECURITIES. ....

United States , San Diego , San Francisco , Kleanthisg Xanthopoulos , Zheng Wei , David Szekeres , Patara Pharma , Steven Chan , Sanford Burnham Preby , Wubin Pan , University Of California , Counsel At Regulus Therapeutics Inc , Warner Lambert Company , Exchange Commission , Roivant Sciences , Heron Therapeutics Inc , Agouron Pharmaceuticals Inc , Company Registration Statement On Form , Exchange Commission On , Edico Genome Inc , Pfizer Inc , Head Of Finance Heron Therapeutics Inc , Duke University School Of Law , Commission File Number , Securities Exchange , Ardea Biosciences Inc ,

Heron Therapeutics, Inc. (NASDAQ:HRTX) Sees Large Growth in Short Interest

Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, an increase of 10.9% from the April 30th total of 27,290,000 shares. Based on an average daily volume of 2,410,000 shares, the short-interest ratio […] ....

Needham Company , Tejara Capital Ltd , Congress Park Capital , Heron Therapeutics Company Profile , Heron Therapeutics Inc , Heron Therapeutics , Get Free Report , One Financial , Capital Management , Asset Management , Spark Capital , Capital Partners , Capital Ltd , Heron Therapeutics Daily ,

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Update

Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, a growth of 10.9% from the April 30th total of 27,290,000 shares. Based on an average trading volume of 2,410,000 shares, […] ....

Jw Asset Management , Heron Therapeutics Inc , Tejara Capital Ltd , Orchard Capital Management , Needham Company , Heron Therapeutics , Get Free Report , Capital Management , Asset Management , Capital Ltd , One Financial , Heron Therapeutics Daily ,

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Up 10.9% in May

Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, an increase of 10.9% from the April 30th total of 27,290,000 shares. Based on an average daily trading volume, of 2,410,000 […] ....

Heron Therapeutics Inc , Tejara Capital Ltd , Heron Therapeutics Company Profile , Needham Company , Jw Asset Management , Orchard Capital Management , Heron Therapeutics , Get Free Report , One Financial , Capital Management , Asset Management , Capital Ltd , Heron Therapeutics Daily ,

Heron Therapeutics announces increased net sales in first-quarter 2024 financial results

Heron Therapeutics Inc. announced increased net product sales in its first quarter of 2024 financial results, according to a company press release.Heron Therapeutics reported $34.7 million in net product sales for the quarter, an increase from its reported $29.6 million in the first quarter of 2023. The company reported $5.5 million in net product sales for its acute care franchise and $29.2 ....

Gina Brockenbrough , Heron Therapeutics Inc , Heron Therapeutics ,